References
- An T Y, Hu L H, Chen Z L. A new xanthone derivative from Hypericum erectum.. Chin Chem Lett 2002; 13: 623–624
- CDC. Staphylococcus areus resistant to vancomycin. U.S. Morbidity and Mortality Weekly Reports 2002; 51: 565–567
- Gibbons S, Moser E, Hausmann S, Stavri M, Smith E, Clennett C. An anti-staphylococcal acylphloroglucinol from Hypericum foliosum.. Phytochemistry 2005; 66: 1472–1475
- Gibbons S, Ohlendorf B, Johnsen I. The genus Hypericum.—a valuable resource of anti-staphylococcal leads. Fitoterapia 2002; 73: 300–304
- Gibbons S, Udo E E. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro. activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus. (MRSA) possessing the tet(K) determinant. Phytother Res 2000; 14: 139–140
- Kaatz G W, Seo S M, Ruble C A. Efflux-mediated fluoroquinolone resistance in staphylococcus aureus. Antimicrobial Agents and Chemotherapy 1993; 37: 1086–1094
- Lin C N, Chung M I, Liou S J, Lee T H, Want J P. Synthesis and anti-inflammatory effects of xanthone derivatives. J Pharm Pharmacol 1996; 48: 532–538
- Luz Cardona M, Seoane E. Xanthone constituents of Hypericum ericoides.. J Nat Prod 1982; 45: 134–136
- Mu Q, Gibbons S, Stavri M, Smith E, Zhou F S, Hu C Q. Antibacterial effects of Hypericum ascyron H. japonicum. against multidrug-resistant (MDR) Staphylococcus aureus.. Pharm Biol 2006; 44: 157–159
- Peeters M J, Sarria J C. Clinical characteristics of linezolid resistant Staphylococcus aureus. infections. Am J Med Sci 2005; 330: 102–104
- Shiu W KP, Gibbons S. Anti-staphylococcal acylphloroglucinols from Hypericum beanie.. Phytochemistry 2006; 67: 2568–2572